Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Articles with Puma Biotechnology
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
News Release
Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today | The Motley Fool
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology falls more than 20%
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Inc
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
